These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16376102)

  • 1. Regulatory T cells in immune surveillance and treatment of cancer.
    Yamaguchi T; Sakaguchi S
    Semin Cancer Biol; 2006 Apr; 16(2):115-23. PubMed ID: 16376102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
    Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
    J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of anti-cancer immunity by regulatory T cells: back to the future.
    Orentas RJ; Kohler ME; Johnson BD
    Semin Cancer Biol; 2006 Apr; 16(2):137-49. PubMed ID: 16376101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.
    Khazaie K; von Boehmer H
    Semin Cancer Biol; 2006 Apr; 16(2):124-36. PubMed ID: 16443370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
    Ono M; Yaguchi H; Ohkura N; Kitabayashi I; Nagamura Y; Nomura T; Miyachi Y; Tsukada T; Sakaguchi S
    Nature; 2007 Apr; 446(7136):685-9. PubMed ID: 17377532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
    Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
    Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
    Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
    Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
    Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
    Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory T cells in tumor immunity.
    Terabe M; Berzofsky JA
    Curr Opin Immunol; 2004 Apr; 16(2):157-62. PubMed ID: 15023407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ CD25+ regulatory T cells control the magnitude of T-dependent humoral immune responses to exogenous antigens.
    Eddahri F; Oldenhove G; Denanglaire S; Urbain J; Leo O; Andris F
    Eur J Immunol; 2006 Apr; 36(4):855-63. PubMed ID: 16511897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.
    Tuve S; Chen BM; Liu Y; Cheng TL; Touré P; Sow PS; Feng Q; Kiviat N; Strauss R; Ni S; Li ZY; Roffler SR; Lieber A
    Cancer Res; 2007 Jun; 67(12):5929-39. PubMed ID: 17575163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent.
    Valzasina B; Piconese S; Guiducci C; Colombo MP
    Cancer Res; 2006 Apr; 66(8):4488-95. PubMed ID: 16618776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation.
    Mahic M; Yaqub S; Bryn T; Henjum K; Eide DM; Torgersen KM; Aandahl EM; Taskén K
    J Leukoc Biol; 2008 May; 83(5):1111-7. PubMed ID: 18270250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4-mediated functional activation of human CD4+CD25+ regulatory T cells.
    Becker C; Kubach J; Wijdenes J; Knop J; Jonuleit H
    Eur J Immunol; 2007 May; 37(5):1217-23. PubMed ID: 17407195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.